customer news Arna Ionescu Stoll customer news Arna Ionescu Stoll

Juno Therapeutics selects the R&D Logic solution for corporate planning and reporting.

September 2014 — Juno, located in Seattle, Washington has selected R&D Logic's software for planning, tracking, anlysis and reporting. Juno is a clinical-stage company that brings together three of the world's leading cancer centers - Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children's Research Institute - in unique partnership to advance a broad pipeline of breakthrough immunotherapies.

Read More
customer news Arna Ionescu Stoll customer news Arna Ionescu Stoll

Mersana Therapeutics selects the R&D Logic time collection solution.

June 2014 — Mersana, located in Cambridge, Massachusetts has selected R&D Logic's software for collecting and reporting project effort and time off. Mersana engineers novel drug conjugates that maximize the potential of new and established therapeutic classes. Mersana technology harnesses the power and synergy of nanotechnology, biologics and small molecules has built a portfolio of innovative therapeutic antibodies, both in late-stage clinical development and in preclinical research.

Read More
customer news Arna Ionescu Stoll customer news Arna Ionescu Stoll

XOMA Corporation selects the R&D Logic platform.

February 2014 — XOMA Corporation, located in Berkeley, California has selected R&D Logic platform to support global planning, tracking and reporting of the R&D porfolio and the overall corporation. XOMA has built a portfolio of innovative therapeutic antibodies, both in late-stage clinical development and in preclinical research.

Read More
customer news Arna Ionescu Stoll customer news Arna Ionescu Stoll

Sutro Biopharma signs up to R&D Logic software and services.

January 2014 — Sutro Biopharma, located in South San Francisco, California has selected R&D Logic software and services to develop long term, mid-term and operational budgetes and to track, analyze and manage variances to actual results. In addition, Sutro employees and contractors will track their time effort to project using the RDLogic platform. Sutro Biopharma is developing a new generation of multi-functional antibody drug conjugate combination therapeutics and bifunctional antibody-based therapeutics for targeted cancer therapies.

Read More